Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002907861 | SCV003243943 | uncertain significance | Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) | 2022-06-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DNAJB6-related conditions. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 258 of the DNAJB6 protein (p.Arg258Cys). This variant is not present in population databases (gnomAD no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004973683 | SCV005578288 | uncertain significance | Inborn genetic diseases | 2024-08-14 | criteria provided, single submitter | clinical testing | The c.772C>T (p.R258C) alteration is located in exon 9 (coding exon 8) of the DNAJB6 gene. This alteration results from a C to T substitution at nucleotide position 772, causing the arginine (R) at amino acid position 258 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |